BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) Stock Price, Quote & AI Analysis

Live BRTX stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for BioRestorative Therapies, Inc. Common Stock (NV).

TradeVae provides AI-driven analysis and real-time market intelligence for BioRestorative Therapies, Inc. Common Stock (NV) (BRTX), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

BRTX
BioRestorative Therapies, Inc. Common Stock (NV)
real-time
$0.00 +0.00 (+0.00%)
Open
1.020000
High
1.070000
Low
1.020000
Volume
19,207
VWAP
-
Market Cap
$9,142,529.26
52W Range
$0.98 - $2.50
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Mar 25, 2026 Q4
Before Open
EPS Estimate: $-0.3825
Revenue Estimate: $306,000.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

BioRestorative Therapies, Inc. Common Stock (NV)'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

BioRestorative Therapies, Inc. Common Stock (NV) Overview

Company information

Company Overview

BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company's initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. BioRestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.

Company Details
Market Cap
$9.14M
Shares Outstanding
8,876,243
Weighted Shares Outstanding
8,876,242
CEO
Lance Alstodt
Address
40 MARCUS DRIVE, MELVILLE, NY, 11747
Employees
11
Industry
SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

BioRestorative Therapies, Inc. Common Stock (NV) Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...